Intestinal ischemia reperfusion injury induced by lipopolysaccharide

SHEN Xiao-fei,ZHAO Yang,CHEN Hui,ZHAO Yong,DU Jun-feng,GUAN Wen-xian
DOI: https://doi.org/10.3877/cma.j.issn.1674-3946.2013.03.059
2013-01-01
Abstract:Obejectives To investigate the effects of lipopolysaccharide (LPS) treatment on intestinal ischemia reperfusion injury and its mechanisms. Methods Mice were assigned randomly into an LPS treatment group (100 μg LPS per mouse,i. p.) ; an ischemia reperfusion group (occlusion of the superior mensenteric artery for 30 minutes,followed by reperfusion) ; and an LPS + I/R group (occlusion of the superior mensenteric artery for 30 minutes,followed by reperfusion and 100 μg LPS per mouse i. p.) . The whole small intestine of the mice was harvested at individual time point after reperfusion, and pathological examination was performed. Total RNA of isolated lymphocytes from the intestinal lamina propria was extracted,and mRNA expression of each proinflammatory cytokine was detected by real-time RT PCR. Results Compared to the LPS treatment group and the ischemia reperfusion group,mRNA expression of proinflammatory cytokines exhibited an accelerated trend in the LPS + I/R group. These results were further confirmed by pathological results showing that the intestinal injury in the LPS + I/R group was severer 48 hours post-reperfusion. There was no significant difference in the mRNA level of IL-17A between the LPS treatment group and the I/R group at the time point of 48 hours [(6. 20 ± 0. 32) vs. (5. 79 ± 0. 30) , t = 3. 117,P > 0. 05]; whereas compared to the other two groups,the mRNA level of IL-17A was significantly increased in the LPS + I/R group[(14. 22 ± 0. 5) vs. (6. 20 ± 0. 32) ,t = 59. 047,P < 0. 05], [(14. 22 ± 0. 5) vs. (5. 79 ± 0. 30) ,t = 134. 754,P < 0. 05]. Conclusion Intestinal ischemia reperfusion injury could be accelerated by exogenous LPS treatment, which might be mediated by IL-17A-producing infiltrated immunocytes.
What problem does this paper attempt to address?